Date du document | Description | Fichier |
---|---|---|
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2022-174 (maize DP910521) from Corteva Agriscience under Regulation (EC) No. 1829/2003 | BAC_2024_1209.pdf | |
Advice of the Belgian Biosafety Advisory Council on application GMFF-2022-5890 (maize MON 95275) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2024_1218.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-027 (EFSA-GMFF-2022-9170 genetically modified Maize MON 89034 x 1507 x MON 88017 x 59122) from Bayer CropScience and Corteva Agriscience under Regulation (EC) No. 1829/2003 | BAC_2024_0807.pdf | |
Advice of the Belgian Biosafety Advisory Council on application GMFF-2022-10651 (maize MON 94804) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2024_0798.pdf | |
Advice of the Belgian Biosafety Advisory Council on application GMFF-2022-3670 (genetically modified crop MON 89034 x 1507 x NK603) from Bayer and Corteva under Regulation (EC) No. 1829/2003 | BAC_2024_0799.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/24/BVW5 of the company Pfizer Inc., for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2024_0752.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/24/BVW4 of the company Sarepta Therapeutics, for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2024_0731.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2019-159 (maize DP202216) from Pioneer under Regulation (EC) No. 1829/2003 | BAC_2024_0636.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/23/BVW3 of the sponsor AstriVax for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2024_0725.pdf | |
Advice of the Belgian Biosafety Advisory Council on notification B/BE/24/V1 from VIB for deliberate release in the environment of genetically modified plants for research and development | BAC_2024_0452.pdf | |
Advice of the Belgian Biosafety Advisory Council on notification B/BE/24/V2 from VIB for deliberate release in the environment of genetically modified plants for research and development | BAC_2024_0455.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2020-172 (maize DP915635) from Pioneer under Regulation (EC) No. 1829/2003 | BAC_2024_0350.pdf | |
Advice of the Belgian Biosafety Advisory Council on notification B/BE/24/V3 from VIB for deliberate release in the environment of genetically modified plants for research and development | BAC_2024_0346.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2019-163 (maize DP23211) from Pioneer under Regulation (EC) No. 1829/2003 | BAC_2024_0349.pdf | |
Advice of the Belgian Biosafety Advisory Council on application GMFF-2022-9450 (genetically modified maize MON810) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2024_0351.pdf | |
Advice of the Belgian Biosafety Advisory Council on notification B/BE/23/V4 from INARI Agriculture N.V. for deliberate release in the environment of genetically modified plants for research and development | BAC_2024_0202.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-DE-2017-141 (cotton COT102) from Syngenta under Regulation (EC) No. 1829/2003 | bac_2023_0891.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-DE-2018-149 (genetically modified maize Bt11 x MIR162 x MIR604 x MON 89034 x 5307 x GA21) from Syngenta under Regulation (EC) No. 1829/2003 | bac_2023_0904.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/22/BVW6 of the company Sarepta Therapeutics, for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | bac_2023_0823.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/22/BVW5 of the company F. Hoffmann-La Roche Ltd for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | bac_2023_0693.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-024 (genetically modified oilseed rape MS8, Rf3 and MS8 x Rf3) from BASF under Regulation (EC) No. 1829/2003 | bac_2023_0605.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/23/BVW2 of the company Janssen-Cilag International NV for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2023_0547.pdf | |
Advice of the Belgian Biosafety Advisory Council on notification B/BE/23/V1 from INARI Agriculture N.V. for deliberate release in the environment of genetically modified plants for research and development | BAC_2023_0338.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-DE-2016-137 (genetically modified maize GA21 x T25) from Syngenta under Regulation (EC) No. 1829/2003 | BAC_2023_0271.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2017-140 (genetically modified maize MON 87419) from Monsanto under Regulation (EC) No. 1829/2003 | BAC_2023_0272.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2020-170 (maize MON 95379) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2023_0106.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-021 (Soybean MON 87701) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2023_0108.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-022 (Soybean MON 87701 x MON 89788) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2023_0109.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2019-161 (maize MON 87429) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2023_0101.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2020-171 (genetically modified maize DP4144 x MON 89034 x MON 87411 x DAS-40278-9) from Pioneer under Regulation (EC) No. 1829/2003 | BAC_2023_0102.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-019 (genetically modified cotton 281-24-236 x 3006-210-23) from Corteva under Regulation (EC) No. 1829/2003 | BAC_2023_0103.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-023 (genetically modified soybean 40-3-2) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2023_0104.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/22/BVW4 of the sponsor Nouscom srl for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2023_0051.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-026/1 (genetically modified oilseed rape GT73) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2022_1402.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-026/2 (genetically modified oilseed rape GT73) from Bayer under Regulation (EC) No. 1829/2003 | BAC_2022_1403.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2020-169 (oilseed rape MON 94100) from Monsanto under Regulation (EC) No. 1829/2003 | BAC_2022_1179.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-025 (genetically modified maize MIR162) from Syngenta under Regulation (EC) No. 1829/2003 | BAC_2022_1181.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-RX-020 (genetically modified soybean A5547-127) from BASF under Regulation (EC) No. 1829/2003 | BAC_2022_1045.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2018-151 (genetically modified maize MON89034 x1507 x MIR162 x NK603 x DAS-40278-9) from Dow AgroSciences under Regulation (EC) No. 1829/2003 | BAC_2022_1053.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/21/BVW7 of the company Boehringer Ingelheim, for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2022_0705.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2018-150 (genetically modified maize DP4114 x MON810 x MIR604 x NK603 and subcombinations) from Pioneer under Regulation (EC) No. 1829/2003 | BAC_2022_0697.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/21/BVW5 of the company Sarepta Therapeutics, for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2022_0677.pdf | |
Advice of the Belgian Biosafety Advisory Councilon the notification B/BE/21/BVW8 of the company MeiraGTx UK II Limited for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2022_0437.pdf | |
Advice of the Belgian Biosafety Advisory Council on notification B/BE/22/V1 from VIB for deliberate release in the environment of genetically modified plants for research and development | BAC_2022_0348.pdf | |
Advice of the Belgian Biosafety Advisory Council on notification B/BE/22/V2 from VIB for deliberate release in the environment of genetically modified plants for research and development | BAC_2022_0349.pdf | |
Advice of the Belgian Biosafety Advisory Council on notification B/BE/22/V3 from VIB for deliberate release in the environment of genetically modified plants for research and development | BAC_2022_0350.pdf | |
Advice of the Belgian Biosafety Advisory Councilon the notification B/BE/21/BVW6 of the company GlaxoSmithKline Biologicals SA for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2022_0243.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/21/BVW4 of the company AMAL Therapeutics, for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2022_0207.pdf | |
Advice of the Belgian Biosafety Advisory Council on application EFSA-GMO-NL-2019-164 (genetically modified maize NK603 x T25 x DAS-40278-9 and subcombinations) from Pioneer under Regulation (EC) No. 1829/2003 | BAC_2022_0153.pdf | |
Advice of the Belgian Biosafety Advisory Council on the notification B/BE/21/BVW3 of the company Prevail Therapeutics, for deliberate release in the environment of genetically modified organisms other than higher plants for research and development | BAC_2021_1036.pdf |